Obstetrics & Gynecology in Lititz, PA
10 verified obstetrics & gynecology doctors in Lititz.
OB/GYNs provide women's reproductive health care, including pregnancy, childbirth, and gynecologic conditions.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Pennsylvania State Board of Medicine
Dr. Michelle Fegley, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kathleen Sheridan, MD
Obstetrics & Gynecology
CMS Open Payments· $16.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.14
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 55th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Kathleen Sheridan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Daniel Kegel, MD
Obstetrics & Gynecology
CMS Open Payments· $6.95 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6.95
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Daniel Kegel do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Thomas Fromuth, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sameera Syed, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Melanie Stone, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jovanni Neblett-Blackmon, MD
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Antonio Vetrano, DO
Obstetrics & Gynecology
CMS Open Payments· $13.23 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$13.23
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 47,072 obstetrics & gynecology doctors we've analyzed, about 47% received any industry payment (median $178 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US obstetrics & gynecology doctors.
Payments to Antonio Vetrano do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Emily Broomell, DO
Obstetrics & Gynecology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.